Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
myelin oligodendrocyte glycoprotein | 0.546 | 0.731 | 0.14 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 1999 | 2013 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2001 | 2010 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 1998 | 2008 | ||||||||
|
2',3'-cyclic nucleotide 3' phosphodiesterase | 0.604 | 0.692 | 0.98 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 1995 | 2011 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 1998 | 2012 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 1998 | 1998 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2002 | 2006 | ||||||||
|
integrin subunit alpha 4 | 0.558 | 0.769 | 1.0E-04 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2003 | 2008 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 1995 | 1997 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 1998 | 2006 | ||||||||
|
C-X3-C motif chemokine receptor 1 | 0.457 | 0.885 | 6.1E-02 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2005 | 2014 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2009 | 2009 | ||||||||
|
C-C motif chemokine receptor 1 | 0.531 | 0.769 | 0.39 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2003 | 2003 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 1996 | 1998 | ||||||||
|
CD4 molecule | 0.604 | 0.654 | 7.9E-04 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 1986 | 1997 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
interleukin 21 | 0.441 | 0.769 | 0.63 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
transforming growth factor beta 2 | 0.433 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
TIMP metallopeptidase inhibitor 3 | 0.445 | 0.923 | 0.63 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
C-C motif chemokine ligand 1 | 0.587 | 0.692 | 8.0E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
C-C motif chemokine ligand 3 | 0.460 | 0.885 | 0.35 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 |